U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

About this Database | Back to Search Page

Guidances | CFR

Search Names Beginning with X

Inactive Ingredient Route Dosage Form CAS Number UNII Maximum Potency per unit dose Maximum Daily Exposure (MDE) Record Updated
XANTHAN GUM OPHTHALMIC SOLUTION 11138662 TTV12P4NEE 0.6%w/v
XANTHAN GUM OPHTHALMIC SOLUTION, GEL FORMING, EXTENDED RELEASE 11138662 TTV12P4NEE 0.6%w/w
XANTHAN GUM OPHTHALMIC SUSPENSION 11138662 TTV12P4NEE 0.6%w/w
XANTHAN GUM ORAL CAPSULE 11138662 TTV12P4NEE 0.01mg
XANTHAN GUM ORAL CAPSULE, EXTENDED RELEASE 11138662 TTV12P4NEE 0.16mg
XANTHAN GUM ORAL FILM, SOLUBLE 11138662 TTV12P4NEE 1mg
XANTHAN GUM ORAL GRANULE, FOR SUSPENSION 11138662 TTV12P4NEE 450mg
XANTHAN GUM ORAL LIQUID, EXTENDED RELEASE 11138662 TTV12P4NEE 50mg
XANTHAN GUM ORAL LOZENGE 11138662 TTV12P4NEE 1,264mg
XANTHAN GUM ORAL PASTE 11138662 TTV12P4NEE 1,050mg Y
XANTHAN GUM ORAL POWDER 11138662 TTV12P4NEE 275mg
XANTHAN GUM ORAL POWDER, FOR SOLUTION 11138662 TTV12P4NEE 10mg/5ml
XANTHAN GUM ORAL POWDER, FOR SUSPENSION 11138662 TTV12P4NEE 600mg
XANTHAN GUM ORAL SOLUTION 11138662 TTV12P4NEE 15mg
XANTHAN GUM ORAL SUSPENSION 11138662 TTV12P4NEE 150mg
XANTHAN GUM ORAL SUSPENSION, EXTENDED RELEASE 11138662 TTV12P4NEE 186.8mg
XANTHAN GUM ORAL SUSPENSION/ DROPS 11138662 TTV12P4NEE 2.9mg/1ml
XANTHAN GUM ORAL TABLET 11138662 TTV12P4NEE 56mg
XANTHAN GUM ORAL TABLET, CHEWABLE, EXTENDED RELEASE 11138662 TTV12P4NEE 6mg
XANTHAN GUM ORAL TABLET, EXTENDED RELEASE 11138662 TTV12P4NEE 528mg
XANTHAN GUM ORAL TABLET, FILM COATED 11138662 TTV12P4NEE 0.08mg
XANTHAN GUM ORAL TABLET, FILM COATED, EXTENDED RELEASE 11138662 TTV12P4NEE 0.03mg
XANTHAN GUM ORAL TABLET, ORALLY DISINTEGRATING 11138662 TTV12P4NEE 0.15mg
XANTHAN GUM ORAL TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE 11138662 TTV12P4NEE 18mg
XANTHAN GUM ORAL TROCHE 11138662 TTV12P4NEE 184mg
XANTHAN GUM RECTAL ENEMA 11138662 TTV12P4NEE 0.25%w/v
XANTHAN GUM RECTAL SUSPENSION 11138662 TTV12P4NEE 0.06%w/v
XANTHAN GUM TOPICAL AEROSOL, FOAM 11138662 TTV12P4NEE 0.27%w/w
XANTHAN GUM TOPICAL CREAM 11138662 TTV12P4NEE 46mg
XANTHAN GUM TOPICAL GEL 11138662 TTV12P4NEE 2.85%w/w
XANTHAN GUM TOPICAL LOTION 11138662 TTV12P4NEE 0.3%w/v
XANTHAN GUM TOPICAL SUSPENSION 11138662 TTV12P4NEE 0.11%w/w
XYLITOL BUCCAL GUM, CHEWING 87990 VCQ006KQ1E 11,915mg Y
XYLITOL ORAL FILM, SOLUBLE 87990 VCQ006KQ1E 4.76mg
XYLITOL ORAL PASTE 87990 VCQ006KQ1E 180mg Y
XYLITOL ORAL POWDER, FOR SUSPENSION 87990 VCQ006KQ1E 4223mg
XYLITOL ORAL SOLUTION 87990 VCQ006KQ1E 21,600mg
XYLITOL ORAL SUSPENSION 87990 VCQ006KQ1E 1,500mg
XYLITOL ORAL SUSPENSION, EXTENDED RELEASE 87990 VCQ006KQ1E 9,000mg
XYLITOL ORAL TABLET 87990 VCQ006KQ1E 15.04mg
XYLITOL ORAL TABLET, EXTENDED RELEASE 87990 VCQ006KQ1E 2,752mg
XYLITOL ORAL TABLET, FILM COATED, EXTENDED RELEASE 87990 VCQ006KQ1E 72mg
XYLITOL ORAL TABLET, ORALLY DISINTEGRATING 87990 VCQ006KQ1E 360mg
XYLITOL SUBLINGUAL SPRAY 87990 VCQ006KQ1E 22mg

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top